by Lunenfeld-Tanenbaum Research Institute Graphical abstract. Credit: Cell Metabolism (2023). DOI: 10.1016/j.cmet.2023.11.009 Researcher Dr. Daniel Drucker has much to be proud of, as the GLP-1-based diabetes drugs hailing from his early research are named the 2023 breakthrough of the year by the Science Magazine. Not only have millions of people with type 2 diabetes benefitted from...
